Hologic Survey Reveals More than Three in Five Women are Unaware that the Density of a Woman's Breasts Impacts Her Risk for Developing Breast Cancer[1]

MARLBOROUGH, Mass., Oct. 1, 2018 /PRNewswire/ --

     WHO:  Hologic, Inc. (Nasdaq: HOLX), is the
             world leader in breast cancer screening
             technology and the maker of the
             Genius(TM) 3D Mammography(TM) exam, the
             only mammogram that is FDA-approved as
             superior to standard 2D mammography for
             routine breast cancer screening of women
             with dense breasts.(2)





     WHAT: Leading OB/GYN Dr. DaCarla Albright is
             joined by Grammy award-winning artist,
             breast cancer survivor and Genius exam
             spokesperson Sheryl Crow to share
             results from Hologic's recent survey,
             conducted online by The Harris Poll
             among over 1,000 U.S. women, designed to
             highlight the need for education about
             breast density and the impact it has on
             breast cancer screening and cancer
             detection.

Hologic survey findings include:

    --  64 percent of U.S. women do not know that the density of a woman's
        breasts impacts her risk of developing breast cancer;
    --  More than two-thirds of U.S women (68 percent) do not know their breast
        density score; and
    --  Just 36 percent of women have discussed their breast density with a
        medical professional - this percentage is slightly higher among women
        ages 40+, at 43 percent.
    --  Knowing that having dense breasts increases a person's risk of
        developing breast cancer, 84% of women would be more likely to go to a
        facility with mammogram technology proven to be more accurate for women
        with dense breasts (compared to standard mammography if all things were
        equal)

The Genius(TM) 3D Mammography(TM) exam (also known as the Genius(TM) exam) is only available on a Hologic® 3D Mammography(TM) system. The Genius(TM) exam consists of a 2D and 3D(TM) image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D(TM) image set. There are more than 5,000 Hologic 3D Mammography(TM) systems in use across the United States, so women have convenient access to the Genius(TM) exam. To learn more about the Genius(TM) exam, visit http://Genius3DNearMe.com.

Media Contact
Jane Mazur
508.263.8764 (direct)
585.355.5978 (mobile)
jane.mazur@hologic.com

(1) HOLOGIC survey, conducted online by The Harris Poll August 14-16, 2018 among 1,155 U.S. women ages 18+, among whom 710 were ages 40+. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact Jane Mazur.
(2) FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hologic-survey-reveals-more-than-three-in-five-women-are-unaware-that-the-density-of-a-womans-breasts-impacts-her-risk-for-developing-breast-cancer1-300721303.html

SOURCE Hologic, Inc.